Lizhu Lin
University of San Diego(US)University of California, San Diego(US)University of California San Diego(US)First Affiliated Hospital of Guangzhou University of Chinese Medicine(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Traditional Chinese Medicine Studies, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials(2018)500 cited
- → Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies(2022)125 cited
- → Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)(2021)93 cited
- → The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues(2018)75 cited
- → Recent pharmacological advances in the repurposing of artemisinin drugs(2021)46 cited
- → An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer(2019)37 cited